Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

New oral treatments for adult hair loss show promise, especially JAK inhibitors, with mild side effects.

Combining TRA and latanoprost is most effective for treating localized alopecia areata.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

Antiandrogens like flutamide are effective in treating conditions like prostate cancer and hair loss, but there's a need for more potent versions. Understanding their structure can help develop better treatments.

Oral betamethasone works faster than oral tofacitinib for hair regrowth in alopecia areata.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Targeting 5α-reductase type 1 may help manage Tourette-like symptoms.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

THAP1 gene changes do not affect DYT1 dystonia; finasteride may help reduce tics and OCD in Tourette syndrome.

Specific mutations in a receptor cause facial abnormalities and hair loss.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Terminalia bellirica extracts effectively promote hair regrowth and treat androgenetic alopecia.

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

New steroids were effective in blocking male hormone receptors in hamster prostates.

Oral pulse steroids reduce TNF-α levels, improving alopecia areata.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

New treatments for male hair loss are being explored to improve effectiveness and reduce side effects.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

Introducing the OTC gene improved symptoms in mice with OTC deficiency.

Tofacitinib may help regrow hair in alopecia areata patients.

PTHRP agonists can stimulate hair growth, especially in damaged follicles, while antagonists may initially increase growth but ultimately inhibit it.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

JAK inhibitors like baricitinib are a new FDA-approved treatment for alopecia areata, but safety data is incomplete.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

Tofacitinib effectively regrows hair in alopecia areata but may need continuous use.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.